Jazz Pharma Plc (JAZZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 1,068,900 | 1,197,967 | 1,126,107 | 1,045,712 | 897,800 |
| Cost of Goods | 134,100 | 153,548 | 128,880 | 116,268 | 104,600 |
| Gross Profit | 934,800 | 1,044,419 | 997,227 | 929,444 | 793,200 |
| Operating Expenses | 598,300 | 790,424 | 940,598 | 1,616,104 | 849,700 |
| Operating Income | 336,600 | 254,543 | 57,509 | -686,392 | -55,900 |
| Interest Expense | 39,900 | 45,412 | 48,576 | 47,363 | 53,700 |
| Other Income | 2,500 | -770 | 55 | -1,885 | -700 |
| Pre-tax Income | 299,200 | 208,361 | 8,988 | -735,640 | -110,300 |
| Income Tax | 6,100 | 4,951 | -242,424 | -17,170 | -17,800 |
| Net Income Continuous | 293,100 | 203,410 | 251,412 | -718,470 | -92,500 |
| Net Income | $293,100 | $203,410 | $251,412 | $-718,470 | $-92,500 |
| EPS Basic Total Ops | 4.73 | 3.28 | 4.14 | -11.74 | -1.52 |
| EPS Basic Continuous Ops | 4.74 | 3.27 | 4.14 | -11.74 | -1.52 |
| EPS Diluted Total Ops | 4.43 | 3.34 | 4.08 | -11.74 | -1.52 |
| EPS Diluted Continuous Ops | 4.43 | 3.34 | 4.08 | -11.74 | -1.52 |
| EPS Diluted Before Non-Recurring Items | 5.46 | 5.76 | 6.99 | -9.07 | 0.60 |
| EBITDA(a) | $518,000 | $433,712 | $235,755 | $-512,310 | $108,900 |